Nautilus Biotechnolgy, Inc.
NAUTNASDAQHealthcareBiotechnology
Previous close
$0.9545
+$0.0522 · +5.79%
Pre-market
$0.9799
+$0.0254 · +2.66%
Aug 24, 7:30 AM ET
NAUT company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
33
Expensive
Momentum
36
Weakening
Sentiment
31
Bearish
Risk resilience
33
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteNautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers single-molecule library preparation kits, flow cells, affinity reagents, and instrument run buffers to perform multi-cycle analysis runs. It has a research collaboration agreement Genentech, Buck Institute, Allen Institute, Cornell University and the Qatar Foundation, and Michael J. Fox Foundation. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Sujal Patel
- Listed since
- Aug 7, 2020
- Employees
- 127
Market position
Day range
Current $0.9545
52-week range
Current $0.9545
- Open
- $0.92
- Previous close
- $0.9023
- Volume
- 852.44K
- 1.22× average
- Average volume
- 700.22K
- Average daily volume
- Market cap
- 121.47M USD
- Beta
- 0.87
- Market reference 1
- 50-day average
- $1.5527
- -38.52% below average
- 200-day average
- $2.2031
- -56.67% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 263.83M USD
- P/E (TTM)
- -2.12×
- P/B (TTM)
- 0.92×
- P/S (TTM)
- 639.29×
- EV / EBITDA
- -5.02×
- Earnings yield
- -23.96%
- Free cash flow yield
- -21.11%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- -919.47%
- Operating margin
- -33043.68%
- Net margin
- -29747.89%
- Return on equity
- -37.59%
- Return on assets
- -30.87%
- Return on invested capital
- -35.74%
Financial health
- Debt / equity
- 0.21×
- Current ratio
- 13.33×
- Altman Z-score
- -1.47
- Piotroski F-score
- 3 of 9
Financial statements
Income trends
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of goods sold | 6.47M USD | 6.35M USD | 5.71M USD | — | 2.84M USD |
| Gross profit | −6.47M USD | −6.35M USD | −5.71M USD | — | −2.84M USD |
| Research and development | 41.11M USD | 50.48M USD | 47.25M USD | 37.67M USD | 26.51M USD |
| Selling, general, and administrative | 25.73M USD | 31M USD | 28.9M USD | 25.95M USD | 21.15M USD |
| Operating expenses | 60.37M USD | 75.12M USD | 70.45M USD | 63.62M USD | 47.66M USD |
| Interest income | 7.87M USD | 10.78M USD | 12.55M USD | 5.82M USD | 329K USD |
| Depreciation and amortization | 6.47M USD | 6.35M USD | 1.85M USD | 3.42M USD | 2.84M USD |
| Operating income | −66.84M USD | −81.48M USD | −76.15M USD | −63.62M USD | −50.5M USD |
| Net income | −59M USD | −70.78M USD | −63.68M USD | −57.92M USD | −50.32M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 100%
- 11 beats, 0 misses, 0 met estimates
- Average EPS surprise
- +16.44%
- 11 comparable reports
- Latest EPS result
- -0.11
- Estimate -0.14 · Beat by 18.52%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$2.50
161.92% upsideRating distribution
5 ratingsRecent analyst actions
NAUT news
NAUT peers
ETFs holding NAUT
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI1.89M0.00%2.3T USD0.03%$378.24+0.44%
iShares Russell 2000 ETFIWM953.16K0.00%81.62B USD0.19%$299.96+0.77%
Vanguard Extended Market ETFVXF530.77K0.00%93.7B USD0.05%$245.53+0.82%
iShares Russell 2000 Value ETFIWN347.18K0.00%14.66B USD0.24%$224.81+0.45%
Vanguard Russell 2000 ETFVTWO274.96K0.00%17.4B USD0.06%$121.25+0.74%
iShares Micro-Cap ETFIWC152.25K0.01%1.53B USD0.60%$198.39+1.10%
iShares Russell 2000 Growth ETFIWO60.53K0.00%15.16B USD0.24%$387.37+1.24%
Vanguard Russell 2000 Value ETFVTWV39.64K0.00%1.4B USD0.06%$198.38+0.34%Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 1.89M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
iShares Russell 2000 ETFIWM- Market value
- 953.16K
- Weight
- 0.00%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Extended Market ETFVXF- Market value
- 530.77K
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Russell 2000 Value ETFIWN- Market value
- 347.18K
- Weight
- 0.00%
- AUM
- 14.66B USD
- Expense ratio
- 0.24%
- Price / 1D
- $224.81+0.45%
Vanguard Russell 2000 ETFVTWO- Market value
- 274.96K
- Weight
- 0.00%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $121.25+0.74%
iShares Micro-Cap ETFIWC- Market value
- 152.25K
- Weight
- 0.01%
- AUM
- 1.53B USD
- Expense ratio
- 0.60%
- Price / 1D
- $198.39+1.10%
iShares Russell 2000 Growth ETFIWO- Market value
- 60.53K
- Weight
- 0.00%
- AUM
- 15.16B USD
- Expense ratio
- 0.24%
- Price / 1D
- $387.37+1.24%
Vanguard Russell 2000 Value ETFVTWV- Market value
- 39.64K
- Weight
- 0.00%
- AUM
- 1.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $198.38+0.34%
Continue in GoAI
Research NAUTresearch.disclaimer